Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Medicine
Volume 2015 (2015), Article ID 203936, 3 pages
http://dx.doi.org/10.1155/2015/203936
Case Report

Baclofen-Induced Encephalopathy in End Stage Renal Disease

Department of Medicine, Temple University Hospital, Philadelphia, PA, USA

Received 6 June 2015; Accepted 22 July 2015

Academic Editor: W. Zidek

Copyright © 2015 Andrew Meillier et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Gerkin, S. C. Curry, M. V. Vance, P. W. Sankowski, and R. D. Meinhart, “First-order elimination kinetics following baclofen overdose,” Annals of Emergency Medicine, vol. 15, no. 7, pp. 843–846, 1986. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Dario and G. Tomei, “A benefit-risk assessment of baclofen in severe spinal spasticity,” Drug Safety, vol. 27, no. 11, pp. 799–818, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. C. Zhang, R. Zhang, S. Zhang, M. Xu, and S. Zhang, “Baclofen for stroke patients with persistent hiccups: a randomized, double-blind, placebo-controlled trial,” Trials, vol. 15, article 295, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. R. R. Young and P. J. Delwaide, “Drug therapy: spasticity (second of two parts),” The New England Journal of Medicine, vol. 304, no. 2, pp. 96–99, 1981. View at Publisher · View at Google Scholar · View at Scopus
  5. C.-L. Chou, C.-A. Chen, S.-H. Lin, and H.-H. Huang, “Baclofen-induced neurotoxicity in chronic renal failure patients with intractable hiccups,” Southern Medical Journal, vol. 99, no. 11, pp. 1308–1309, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Brvar, M. Vrtovec, D. Kovač, G. Kozelj, T. Pezdir, and M. Bunc, “Haemodialysis clearance of baclofen,” European Journal of Clinical Pharmacology, vol. 63, no. 12, pp. 1143–1146, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. N. E. F. Cartlidge, P. Hudgson, and D. Weightman, “A comparison of baclofen and diazepam in the treatment of spasticity,” Journal of the Neurological Sciences, vol. 23, no. 1, pp. 17–24, 1974. View at Publisher · View at Google Scholar · View at Scopus
  8. E. W. Wuis, M. J. M. Dirks, E. F. S. Termond, T. B. Vree, and E. Van der Kleijn, “Plasma and urinary excretion kinetics of oral baclofen in healthy subjects,” European Journal of Clinical Pharmacology, vol. 37, no. 2, pp. 181–184, 1989. View at Publisher · View at Google Scholar · View at Scopus
  9. L. S. Dias, G. Vivek, M. Manthappa, and R. V. Acharya, “Role of hemodialysis in baclofen overdose with normal renal function,” Indian Journal of Pharmacology, vol. 43, no. 6, pp. 722–723, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. K.-S. Chen, M. J. Bullard, Y.-Y. Chien, and S.-Y. Lee, “Baclofen toxicity in patients with severely impaired renal function,” Annals of Pharmacotherapy, vol. 31, no. 11, pp. 1315–1320, 1997. View at Google Scholar · View at Scopus
  11. V.-C. Wu, S.-L. Lin, S.-M. Lin, and C.-C. Fang, “Treatment of baclofen overdose by haemodialysis: a pharmacokinetic study,” Nephrology Dialysis Transplantation, vol. 20, no. 2, pp. 441–443, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. B. Sauneuf, H. K. Totouom, B. Savary et al., “Clinical and EEG features of acute intrathecal baclofen overdose,” Clinical Neurology and Neurosurgery, vol. 114, no. 1, pp. 84–86, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. T. Fakhoury, B. Abou-Khalil, and B. Blumenkopf, “EEG changes in intrathecal baclofen overdose: a case report and review of the literature,” Electroencephalography and Clinical Neurophysiology, vol. 107, no. 5, pp. 339–342, 1998. View at Publisher · View at Google Scholar · View at Scopus
  14. A. El-Husseini, A. Sabucedo, J. Lamarche, C. Courville, and A. Peguero, “Baclofen toxicity in patients with advanced nephropathy: proposal for new labeling,” American Journal of Nephrology, vol. 34, no. 6, pp. 491–495, 2011. View at Publisher · View at Google Scholar · View at Scopus